Improved survival in stage IB/II melanoma using Canvaxin™, a polyvalent cancer vaccine

被引：0
|
作者：
Faries, MB [1 ]
Foshag, LJ [1 ]
Essner, R [1 ]
Wanek, LA [1 ]
Morton, DL [1 ]
机构：
[1] John Wayne Canc Inst, Santa Monica, CA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2005年 / 12卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [1] Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine
    Hsueh, EC
    Morton, DL
    SEMINARS IN CANCER BIOLOGY, 2003, 13 (06) : 401 - 407
  • [2] IMPROVED SURVIVAL OF PATIENTS WITH MELANOMA WITH AN ANTIBODY-RESPONSE TO IMMUNIZATION TO A POLYVALENT MELANOMA VACCINE
    MILLER, K
    ABELES, G
    ORATZ, R
    ZELENIUCHJACQUOTTE, A
    CUI, J
    ROSES, DF
    HARRIS, MN
    BYSTRYN, JC
    CANCER, 1995, 75 (02) : 495 - 502
  • [3] Active specific immunotherapy with a polyvalent cancer vaccine prolongs survival in AJCC stage IV melanoma.
    Morton, DL
    Essner, R
    Hsueh, EC
    Wanek, LA
    Foshag, LJ
    O'Day, SJ
    Gupta, RK
    Hoon, DS
    Gammon, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 173S - 173S
  • [4] POLYVALENT MELANOMA VACCINE IMPROVES SURVIVAL OF PATIENTS WITH METASTATIC MELANOMA
    MORTON, DL
    HOON, DSB
    NIZZE, JA
    FOSHAG, LJ
    FAMATIGA, E
    WANEK, LA
    CHANG, C
    IRIE, RF
    GUPTA, RK
    ELASHOFF, R
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 690 : 120 - 134
  • [5] Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: An immunologic survival model
    Jones, RC
    Kelley, M
    Gupta, RK
    Nizze, JA
    Yee, R
    Leopoldo, Z
    Qi, K
    Stern, S
    Morton, DL
    ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (05) : 437 - 445
  • [6] Prolonged survival of patients receiving active immunotherapy with canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes
    Morton, DL
    Hsueh, EC
    Essner, R
    Foshag, LJ
    O'Day, SJ
    Bilchik, A
    Gupta, RK
    Hoon, DSB
    Ravindranath, M
    Nizze, JA
    Gammon, G
    Wanek, LA
    Wang, HJ
    Elashoff, RM
    ANNALS OF SURGERY, 2002, 236 (04) : 438 - 449
  • [7] Enhanced humoral immune response correlates with improved disease-free and overall survival in American joint committee on cancer stage II melanoma patients receiving adjuvant polyvalent vaccine
    DiFronzo, LA
    Gupta, RK
    Essner, R
    Foshag, LJ
    O'Day, SJ
    Wanek, LA
    Stern, SL
    Morton, DL
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) : 3242 - 3248
  • [8] Long-term survival of stage IV melanoma patients treated with a polyvalent, shed antigen, melanoma vaccine
    Laky, D
    Shapiro, RL
    Harris, MN
    Roses, DF
    Jacquotte, AZ
    Reynolds, SR
    Bystryn, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 240 - 240
  • [9] Active immunotherapy by reinduction with a polyvalent allogeneic cell vaccine correlates with improved survival in recurrent metastatic melanoma
    Hsueh, EC
    Essner, R
    Foshag, LJ
    Ye, W
    Morton, DL
    ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (05) : 486 - 492
  • [10] Active immunotherapy by reinduction with a polyvalent allogeneic cell vaccine correlates with improved survival in recurrent metastatic melanoma
    Eddy C. Hsueh
    Richard Essner
    Leland J. Foshag
    Wei Ye
    Donald L. Morton
    Annals of Surgical Oncology, 2002, 9 (5) : 486 - 492
12345